Insights - Page 49 of 107 - LucidQuest Ventures

Lucid Diligence Brief: Human Health A$8.5m raise in women’s health

October 31, 2025digital health,clinical trials,market access,reimbursement,Regulatory,AI in healthcare,Lucid Diligence Brief,payer access,diligence,HTAfemtech

Lucid Diligence Brief: Human Health A$8.5m raise in women’s health Professional…

by Timos Papagatsias

Cardiovascular Today—October 30, 2025

October 30, 2025semaglutide,BioPharma and Tech News,Renal Denervation,Medtronic,Cardiovascular News,Ventyx Biosciences,TCT 2025,Coronary and Structural InterventionsNLRP3 inhibitor,Ancora Heart

This week in cardiovascular: the latest clinical updates, industry progress,…

by LucidQuest

Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera

October 30, 2025clinical trials,market access,Regulatory,GLP-1,biopharma,Lucid Diligence Brief,payer access,diligence,M&Aobesity drugs

Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…

by Timos Papagatsias

Cell and Gene Therapy Video Recap—October 30, 2025

October 30, 2025BioPharma and Tech News,Eli LillyRett syndrome,Cell and Gene Therapy News,Phase 3 clinical trial,Astellas Pharma,ISP-001,LGMD2I/R9,FDA Fast Track designation,Pipeline investment

In this biweekly edition, we cover the most significant developments shaping…

by LucidQuest

Cell and Gene Therapy Today—October 30, 2025

October 30, 2025BioPharma and Tech News,autoimmune diseasesCAR T Therapy,Bristol Myers Squibb,Cell and Gene Therapy News,Amyloid transthyretin cardiomyopathy,Intellia Therapeutics,Ixo-vec gene therapy,Thymus-targeted Tregs,Phase 3 clinical trial

This week’s Gene & Cell Therapy news delivers the latest updates,…

by LucidQuest

Women’s Health Video Recap—October 29, 2025

October 30, 2025BioPharma and Tech News,menopauseGates Foundation,Women's Health News,BioMed X,Hims & Hers Health,HLTH

This biweekly women’s health video highlights policy/regulatory updates,…

by LucidQuest

Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration

October 30, 2025biopharma,Regeneron,immuno-oncology,Lucid Diligence Brief,payer access,diligence,platform biotech,partnerships,multispecific antibodies,CMC riskOPKO

Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration…

by Timos Papagatsias

Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership

October 29, 2025clinical trials,drug discovery,AI in healthcare,biopharma,Lucid Diligence Brief,payer access,diligence,manufacturing,supercomputing,federated learningNVIDIA Blackwell

Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership…

by Timos Papagatsias

Neuroscience Video Recap—October 29, 2025

October 29, 2025novartis,Duchenne Muscular Dystrophy,BioPharma and Tech News,Avidity Biosciences,Bristol Myers Squibb,Neuroscience News,BridgeBiomyotonic dystrophy type 1,facioscapulohumeral muscular dystrophy

In this video, we take a closer look at the newest updates in Neuroscience:…

by LucidQuest

Immunology Today — October 29, 2025

October 29, 2025novartis,BioPharma and Tech News,Ulcerative Colitis,Crohns Disease,Sjögrens Disease,Johnson & Johnson,Bristol Myers Squibb,Immunology News,Systemic lupus erythematosus,CAR T cell therapyIL-23 pathway,FcRn inhibitors

This week’s immunology update spotlights key developments, regulatory…

by LucidQuest

Neuroscience Today — October 29, 2025

October 29, 2025novartis,Duchenne Muscular Dystrophy,BioPharma and Tech News,epilepsy,AI drug discovery,Neuroscience News,Zenas BioPharma,Limb-Girdle Muscular Dystrophy,Relapsing multiple sclerosis,RNA-targeting therapeuticsAntibody–oligonucleotide conjugates,BridgeBio

Get up to speed with this week’s neuroscience news, featuring clinical…

by LucidQuest

Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD

October 29, 2025Respiratory,clinical trials,market access,Regulatory,COPD,biopharma,Lucid Diligence Brief,payer access,diligence,RNAioligonucleotides

Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…

by Timos Papagatsias

Minimize Uncertainty – Make Informed Decisions – Succeed